32 related articles for article (PubMed ID: 9930342)
1. Comparison of Three Different Methods of Transfection for the Production of Recombinant Adenovirus Expressing Human Carcinoembryonic Antigen Gene.
Yari A; Bamdad T; Hosseini SY
Arch Razi Inst; 2023 Jun; 78(3):1057-1064. PubMed ID: 38028844
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of liver cancer with a recombinant DNA vaccine containing the hemagglutinin-neuraminidase gene of Newcastle disease virus via apoptotic-dependent pathways.
Chen LG; Liu YS; Zheng TH; Chen X; Li P; Xiao CX; Ren JL
Oncol Lett; 2016 Nov; 12(5):3344-3350. PubMed ID: 27900002
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific gene expression using the survivin promoter is further increased by hypoxia.
Yang L; Cao Z; Li F; Post DE; Van Meir EG; Zhong H; Wood WC
Gene Ther; 2004 Aug; 11(15):1215-23. PubMed ID: 15141159
[TBL] [Abstract][Full Text] [Related]
4. Transcriptionally targeted gene therapy to detect and treat cancer.
Wu L; Johnson M; Sato M
Trends Mol Med; 2003 Oct; 9(10):421-9. PubMed ID: 14557054
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional Targeting in Cancer Gene Therapy.
Robson T; Hirst DG
J Biomed Biotechnol; 2003; 2003(2):110-137. PubMed ID: 12721516
[TBL] [Abstract][Full Text] [Related]
6. A novel HBV antisense RNA gene delivery system targeting hepatocellular carcinoma.
Ma CH; Sun WS; Tian PK; Gao LF; Liu SX; Wang XY; Zhang LN; Cao YL; Han LH; Liang XH
World J Gastroenterol; 2003 Mar; 9(3):463-7. PubMed ID: 12632498
[TBL] [Abstract][Full Text] [Related]
7. Development of gene therapy using prostate-specific membrane antigen promoter/enhancer with Cre Recombinase/LoxP system for prostate cancer cells under androgen ablation condition.
Ikegami S; Tadakuma T; Suzuki S; Yoshimura I; Asano T; Hayakawa M
Jpn J Cancer Res; 2002 Oct; 93(10):1154-63. PubMed ID: 12417046
[TBL] [Abstract][Full Text] [Related]
8. p53 gene therapy in vivo of herpatocellular and liver metastatic colorectal cancer.
Bookstein R; Demers W; Gregory R; Maneval D; Park J; Wills K
Semin Oncol; 1996 Feb; 23(1):66-77. PubMed ID: 8607033
[TBL] [Abstract][Full Text] [Related]
9. [Adenovirus gene therapy for liver metastases of gastrointestinal tumors. Development status and future prospectives].
Block A; Windler E; Greten H; Woo SL
Dtsch Med Wochenschr; 1997 May; 122(22):728-32. PubMed ID: 9213538
[No Abstract] [Full Text] [Related]
10. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach.
Brand K; Löser P; Arnold W; Bartels T; Strauss M
Gene Ther; 1998 Oct; 5(10):1363-71. PubMed ID: 9930342
[TBL] [Abstract][Full Text] [Related]
11. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
[TBL] [Abstract][Full Text] [Related]
12. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors.
Brand K; Arnold W; Bartels T; Lieber A; Kay MA; Strauss M; Dörken B
Cancer Gene Ther; 1997; 4(1):9-16. PubMed ID: 9012446
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific transcriptional targeting of suicide gene therapy.
Qiao J; Doubrovin M; Sauter BV; Huang Y; Guo ZS; Balatoni J; Akhurst T; Blasberg RG; Tjuvajev JG; Chen SH; Woo SL
Gene Ther; 2002 Feb; 9(3):168-75. PubMed ID: 11859419
[TBL] [Abstract][Full Text] [Related]
14. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration.
van der Eb MM; Cramer SJ; Vergouwe Y; Schagen FH; van Krieken JH; van der Eb AJ; Borel Rinkes IH; van de Velde CJ; Hoeben RC
Gene Ther; 1998 Apr; 5(4):451-8. PubMed ID: 9614568
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
